Three major oncology organizations recommend that CEA be measured in patients with nonmetastatic colorectal cancer prior to surgical resection. In the current analysis, patients with a normal ...
Background: The usefulness of tumor markers in NSCLC is not well defined. High levels of CEA are considered a negative prognostic factor in early-stages NSCLC but its role in advanced disease is yet ...
These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...
Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with ...
Tissue microarray analysis to evaluate the role of heat shock protein 27 as a potential biomarker in pancreatic cancer. Background: The usefulness of tumor markers in NSCLC is not well defined. High ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback